Pliant Therapeutics (PLRX) Earnings Date & Reports

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PLRX is expected to report earnings to fall 27.46% to -66 cents per share on August 11

Pliant Therapeutics PLRX Stock Earnings Reports

Q2'25

Est.

$-0.67

Q1'25

Missed

by $0.15

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.07

The last earnings report on May 08 showed earnings per share of -92 cents, missing the estimate of -76 cents. With 282.94K shares outstanding, the current market capitalization sits at 82.26M.

View a ticker or compare two or three

Compare

PLRX